General Information of Drug (ID: DM19CFZ)

Drug Name
DIMS-0150 Drug Info
Synonyms Kappaproct; Antisense NF-kBp65 oligonucleotide (IBD), InDex Pharmaceuticals; Antisense NF-kBp65 oligonucleotide (IBD), Serono; Antisense NF-kBp65 oligonucleotide (inflammatory bowel disease), Serono
Indication
Disease Entry ICD 11 Status REF
Ulcerative colitis DD71 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DM19CFZ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
NFKB messenger RNA (NFKB mRNA) TTKLNRV NFKB2_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT01493960) The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients. U.S. National Institutes of Health.
2 News and Analysis. Nature Reviews Drug Discovery 12, 179 (March 2013).